Literature DB >> 23494849

GPSM2 and Chudley-McCullough syndrome: a Dutch founder variant brought to North America.

Rowida Almomani1, Yu Sun, Emmelien Aten, Yvonne Hilhorst-Hofstee, Cacha M P C D Peeters-Scholte, Arie van Haeringen, Yvonne M C Hendriks, Johan T den Dunnen, Martijn H Breuning, Marjolein Kriek, Gijs W E Santen.   

Abstract

Chudley-McCullough syndrome (CMS) is characterized by profound sensorineural hearing loss and brain anomalies. Variants in GPSM2 have recently been reported as a cause of CMS by Doherty et al. In this study we have performed exome sequencing of three CMS patients from two unrelated families from the same Dutch village. We identified one homozygous frameshift GPSM2 variants c.1473delG in all patients. We show that this variant arises from a shared, rare haplotype. Since the c.1473delG variant was found in Mennonite settlers, it likely originated in Europe. To support DNA diagnostics, we established an LOVD database for GPSM2 containing all variants thus far described.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494849     DOI: 10.1002/ajmg.a.35808

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  The GPSM2/LGN GoLoco motifs are essential for hearing.

Authors:  Yoni Bhonker; Amal Abu-Rayyan; Kathy Ushakov; Liat Amir-Zilberstein; Shaked Shivatzki; Ofer Yizhar-Barnea; Tal Elkan-Miller; Einav Tayeb-Fligelman; Sun Myoung Kim; Meytal Landau; Moien Kanaan; Ping Chen; Fumio Matsuzaki; David Sprinzak; Karen B Avraham
Journal:  Mamm Genome       Date:  2015-12-11       Impact factor: 2.957

Review 2.  Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad.

Authors:  Joe B Blumer; Stephen M Lanier
Journal:  Mol Pharmacol       Date:  2013-12-03       Impact factor: 4.436

3.  Prenatal diagnosis of Chudley-McCullough syndrome.

Authors:  Teresa Chapman; Francisco A Perez; Gisele E Ishak; Dan Doherty
Journal:  Am J Med Genet A       Date:  2016-06-17       Impact factor: 2.802

4.  With expanded carrier screening, founder populations run the risk of being overlooked.

Authors:  Inge B Mathijssen; Merel C van Maarle; Iris I M Kleiss; Egbert J W Redeker; Leo P Ten Kate; Lidewij Henneman; Hanne Meijers-Heijboer
Journal:  J Community Genet       Date:  2017-05-29

5.  Chudley-McCullough Syndrome.

Authors:  Meltem Özdemir; Alper Dilli
Journal:  J Clin Imaging Sci       Date:  2018-11-15

6.  G-protein-signaling modulator 2 expression and role in a CD133+ pancreatic cancer stem cell subset.

Authors:  Sheng-Chun Dang; Xiao-Bao Qian; Wei Jin; Lei Cui; Ji-Xiang Chen; Min Gu
Journal:  Onco Targets Ther       Date:  2019-01-23       Impact factor: 4.147

7.  Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis.

Authors:  Mingming Deng; Zhe Zhang; Bofang Liu; Kezuo Hou; Xiaofang Che; Xiujuan Qu; Yunpeng Liu; Xuejun Hu; Ye Zhang; Qingjie Lv
Journal:  Front Oncol       Date:  2020-03-03       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.